CacyBP/SIP inhibits Doxourbicin‐induced apoptosis of glioma cells due to activation of ERK1/2

Calcyclin‐binding protein or Siah‐1‐interacting protein (CacyBP/SIP) was previously reported to promote the proliferation of glioma cells. However, the effect of CacyBP/SIP on apoptosis of glioma is poorly understood. Here, our study shows that CacyBP/SIP plays a role in inhibiting doxorubicin (DOX) induced apoptosis of glioma cells U251 and U87. Overexpression of CacyBP/SIP obviously suppressed the DOX‐induced cell apoptosis. On the contrary, silencing of CacyBP/SIP significantly promoted it. Further investigation indicated that inhibition of apoptosis by CacyBP/SIP was relevant to its nuclear translocation in response to the DOX treatment. Importantly, we found that the level of p‐ERK1/2 in nuclei was related to the nuclear accumulation of CacyBP/SIP. Finally, the role of CacyBP/SIP was confirmed in vivo in a mouse model with the cell line stably silencing CacyBP/SIP. Taken together, our results suggest that CacyBP/SIP plays an important role in inhibiting apoptosis of glioma cells which might be mediated by ERK1/2 signaling pathway, which will provide some guidance for the treatment of glioma. © 2016 IUBMB Life, 68(3):211–219, 2016

[1]  Y. Li,et al.  The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis , 2014, Journal of cellular and molecular medicine.

[2]  Q. Shi,et al.  CacyBP/SIP protein is important for the proliferation of human glioma cells , 2014, IUBMB life.

[3]  T. Lim,et al.  iTRAQ Based Quantitative Proteomics Approach Validated the Role of Calcyclin Binding Protein (CacyBP) in Promoting Colorectal Cancer Metastasis* , 2013, Molecular & Cellular Proteomics.

[4]  A. Filipek,et al.  CacyBP/SIP as a novel modulator of the thin filament. , 2013, Biochimica et biophysica acta.

[5]  A. Filipek,et al.  Up-regulation of CacyBP/SIP during rat breast cancer development , 2012, Breast Cancer.

[6]  R. Roskoski.  ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[7]  Xuesi Chen,et al.  Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy. , 2012, Biomaterials.

[8]  Urszula Wasik,et al.  CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[9]  Hyung-Ryong Kim,et al.  Doxorubicin- and daunorubicin-induced regulation of Ca2+ and H+ fluxes through human bax inhibitor-1 reconstituted into membranes. , 2012, Journal of pharmaceutical sciences.

[10]  Xiaohua Li,et al.  CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells , 2011, Molecular carcinogenesis.

[11]  S. Filipek,et al.  ERK1/2 is dephosphorylated by a novel phosphatase--CacyBP/SIP. , 2011, Biochemical and biophysical research communications.

[12]  A. Filipek,et al.  S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function , 2011, Amino Acids.

[13]  J. Yang,et al.  Identification of Siah-interacting protein as a potential regulator of apoptosis and curcumin resistance , 2010, Oncogene.

[14]  A. Filipek,et al.  Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. , 2010, Biochimica et biophysica acta.

[15]  Q. Ma,et al.  CacyBP/SIP Expression is Involved in the Clinical Progression of Breast Cancer , 2010, World Journal of Surgery.

[16]  S. Filipek,et al.  CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. , 2009, Biochemical and biophysical research communications.

[17]  Haifeng Jin,et al.  Expression of Calcyclin-binding Protein/Siah-1 Interacting Protein in Normal and Malignant Human Tissues: An Immunohistochemical Survey , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  A. Basu,et al.  Protein kinase Cɛ confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53 , 2008, Oncogene.

[19]  K. Jang,et al.  Fatty acids ameliorate doxorubicin-induced intracellular ca2+ increase and apoptosis in rat cardiomyocytes. , 2008, Biological & pharmaceutical bulletin.

[20]  Liu Hong,et al.  Calcyclin-Binding Protein Inhibits Proliferation, Tumorigenicity, and Invasion of Gastric Cancer , 2007, Molecular Cancer Research.

[21]  J. Kuźnicki,et al.  CacyBP/SIP interacts with tubulin in neuroblastoma NB2a cells and induces formation of globular tubulin assemblies. , 2007, Biochimica et biophysica acta.

[22]  Kaichun Wu,et al.  Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. , 2007, Biochemical and biophysical research communications.

[23]  S. Tsui,et al.  Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes , 2006, Journal of cellular biochemistry.

[24]  W. Kolch.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[25]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[26]  N. Anderson,et al.  The isoform-specific regulation of apoptosis by protein kinase C , 2003, Cellular and Molecular Life Sciences CMLS.

[27]  J. Kuźnicki,et al.  CacyBP/SIP, a Calcyclin and Siah-1-interacting Protein, Binds EF-hand Proteins of the S100 Family* , 2002, The Journal of Biological Chemistry.

[28]  J. Kuźnicki,et al.  Ca2+-dependent Translocation of the Calcyclin-binding Protein in Neurons and Neuroblastoma NB-2a Cells* , 2002, The Journal of Biological Chemistry.

[29]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[30]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[31]  M. Dai,et al.  Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. , 2000, Journal of hematotherapy & stem cell research.

[32]  X. Chen,et al.  Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. , 1999, The Journal of biological chemistry.

[33]  A. Filipek,et al.  p30, a novel protein target of mouse calcyclin (S100A6). , 1996, The Biochemical journal.

[34]  E. Goldsmith,et al.  Contributions of the Mitogen-activated Protein (MAP) Kinase Backbone and Phosphorylation Loop to MEK Specificity* , 1996, The Journal of Biological Chemistry.

[35]  K. Guan,et al.  Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase. , 1993, The Journal of biological chemistry.